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Cathepsin D protects colorectal cancer cells from
acetate-induced apoptosis through autophagy-
independent degradation of damaged mitochondria
CSF Oliveira1,2, H Pereira1, S Alves1, L Castro1, F Baltazar3,4, SR Chaves1, A Preto1,5 and M Côrte-Real*,1,5
Acetate is a short-chain fatty acid secreted by Propionibacteria from the human intestine, known to induce mitochondrial apoptotic
death in colorectal cancer (CRC) cells. We previously established that acetate also induces lysosome membrane permeabilization
in CRC cells, associated with release of the lysosomal protease cathepsin D (CatD), which has a well-established role in the
mitochondrial apoptotic cascade. Unexpectedly, we showed that CatD has an antiapoptotic role in this process, as pepstatin A
(a CatD inhibitor) increased acetate-induced apoptosis. These results mimicked our previous data in the yeast system showing
that acetic acid activates a mitochondria-dependent apoptosis process associated with vacuolar membrane permeabilization and
release of the vacuolar protease Pep4p, ortholog of mammalian CatD. Indeed, this protease was required for cell survival in a
manner dependent on its catalytic activity and for efficient mitochondrial degradation independently of autophagy. In this study, we
therefore assessed the role of CatD in acetate-induced mitochondrial alterations. We found that, similar to acetic acid in yeast,
acetate-induced apoptosis is not associated with autophagy induction in CRC cells. Moreover, inhibition of CatD with small
interfering RNA or pepstatin A enhanced apoptosis associated with higher mitochondrial dysfunction and increased mitochondrial
mass. This effect seems to be specific, as inhibition of CatB and CatL with E-64d had no effect, nor were these proteases
significantly released to the cytosol during acetate-induced apoptosis. Using yeast cells, we further show that the role of Pep4p in
mitochondrial degradation depends on its protease activity and is complemented by CatD, indicating that this mechanism is
conserved. In summary, the clues provided by the yeast model unveiled a novel CatD function in the degradation of damaged
mitochondria when autophagy is impaired, which protects CRC cells from acetate-induced apoptosis. CatD inhibitors could
therefore enhance acetate-mediated cancer cell death, presenting a novel strategy for prevention or therapy of CRC.
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Colorectal cancer (CRC) is one of the most common cancers
worldwide.1,2 In Europe, it is the most diagnosed malignancy
and the second cause of cancer mortality in both genders,2
highlighting the need for novel strategies to prevent and treat
CRC. Short-chain fatty acids (SCFA), namely butyrate,
propionate and acetate, are the major by-products of
anaerobic bacterial fermentation of undigested fibers in the
human colon. As they were reported as antiproliferative and
antineoplastic agents that induce differentiation, growth arrest
and apoptosis in CRC cell lines,3–6 there has been increased
interest in exploiting these natural products in CRC prevention
and therapy. The antitumor effect of SCFAs stems from their
ability to induce cell death involving mitochondria-mediated
apoptosis (caspase-dependent/independent) or necrosis in
colon cancer cells.3,4,6 We also previously implicated another
organelle in acetate-induced apoptosis, the lysosome. Indeed,
lysosomal membrane permeabilization (LMP) and release of
cathepsins into the cytosol can initiate the lysosomal apoptotic
pathway either in a mitochondria-independent manner or
mediated by mitochondrial destabilization with subsequent
release of apoptotic factors.7,8 Among the cathepsins released
by LMP, cathepsin D (CatD), originally considered a ‘house-
keeping enzyme’9 necessary for autophagy10 can act as an
antiapoptotic or proapoptotic mediator depending on the cell
type and context.10–12 However, the exact mechanisms
triggered by CatD following LMP in cancer cells, as well as
the signaling to and/or from mitochondria, remain to be
clarified.
In a previous study, we demonstrated that CatD is released
into the cytosol and protects cells undergoing acetate-induced
apoptosis.5 These results were in agreement with our data
showing that Pep4p, the yeast ortholog of human CatD,
translocates from the vacuole to the cytosol during
mitochondria-mediated acetic acid-induced apoptosis in
Saccharomyces cerevisiae,13 and that it has a protective role
in this process dependent on its catalytic activity.14 However,
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the mechanisms by which CatD protects CRC cells from
acetate exposure are still unknown. It had been shown that
SCFAs (namely butyrate and propionate) induce autophagy in
CRC cells, which serves as an adaptive strategy to delay
mitochondria-mediated apoptotic cell death.15–17 In contrast,
we showed that yeast CatD is involved in acetic acid-induced
mitochondrial degradation independently of autophagy.13
We therefore hypothesized the same would occur in the
response of CRC cells to acetate. In this work, we assessed
how CatD affects the mitochondrial alterations induced by
acetate in CRC cell lines, and specifically evaluated its role in
mitochondrial degradation. Our results indicate that the
antineoplastic mechanism of acetate is characterized by an
accumulation of reactive oxygen species (ROS) and changes
in mitochondrial mass and mitochondrial membrane potential
(ΔΨm). We further show that CatD, but not CatB or CatL, is
involved in the degradation of the dysfunctional mitochondria
to enhance CRC cell survival in response to acetate, which
impairs autophagy. Our data therefore indicate that acetate-
induced apoptosis involves cross-talk between the lysosome
and mitochondria, and support using probiotics and inhibiting
CatD as a prevention or therapeutic strategy in CRC.
Results
Acetate leads to oxidative stress, changes in ΔΨm and
increased mitochondrial mass in CRC cells. Acetate-
induced apoptosis has been associated with mitochondrial
dysfunction, including increased ROS and ΔΨm alterations,
although only in HT-29 cells.3,4 We also previously showed
that CRC-derived cells HCT-15 and RKO exposed to
physiological concentrations of acetate exhibit characteristic
apoptotic markers.5 However, an effect on mitochondrial
mass, as suggested by our studies in yeast,13 has never been
described. We therefore sought to determine comprehen-
sively how acetate affects mitochondrial function in HCT-15
and RKO cells, in particular ROS accumulation and changes
in ΔΨm and mitochondrial mass. For this purpose, cells
exposed to different concentrations of acetate were stained
with the ROS probes 2,7-dihydrodichlorofluorescein diacetate
(H2DCF-DA) or dihydroethidium (DHE), to detect hydrogen
peroxide (H2O2) or superoxide anion (O2
−), respectively. ROS
levels in HCT-15 and RKO cells consistently increased in
response to acetate in a dose-dependent manner after 12
and 24 h of exposure, and then slightly decreased after 48 h
(H2O2 in HCT-15 (Figure 1a) and RKO cells (not shown), and
O2
− in RKO cells (Figure 1b)). To determine if the acetate-
induced ROS accumulation could be due to inhibition of
cellular antioxidant defenses, we used a qualitative assay
to measure catalase activity.18 We found that exposure to a
half-maximal inhibitory concentration (IC50) of acetate slightly
decreased catalase activity in HCT-15 and RKO cells,
although more evidently in the latter (Supplementary Figure
S1).
In addition to resulting from a decrease in antioxidant
defenses, ROS accumulation can be an early event of the
apoptotic process, associated with other mitochondrial
dysfunctions.19 We therefore assessed if acetate induces
further mitochondrial alterations in CRC cells. We found that
acetate, similar to CCCP (carbonyl cyanide m-chlorophenyl-
hydrazone), decreased the ΔΨm, as it lowered mitochondrial
accumulation of DiOC6(3) and of MitoTracker Red CMXRos in
RKO cells and of DiOC6(3) in HCT-15 cells (Supplementary
Figure S2), while increasing cytosolic fluorescence of the
probes. As changes in ΔΨm can result from changes in
mitochondrial mass, we quantitatively assessed these two
parameters simultaneously in RKO cells stained with both
MitoTracker Red CMXRos and MitoTracker Green FM, by
flow cytometry. In addition to a decrease in the mean red
fluorescence, indicative of decreased ΔΨm (Figure 1c),
acetate increased the mean green fluorescence, indicative
of an increase in mitochondrial mass (Figures 1c and d). After
normalizing acetate-induced changes in ΔΨm tomitochondrial
mass, and in relation to time zero (Figure 1e), it became
evident that a short exposure to acetate induces a small
increase in ΔΨm (Figure 1e). This hyperpolarization was
apparent after 12 h of exposure to 110 and 140mM but not to
220mM acetate. For longer exposure times, this ratio
significantly decreased for all concentrations, indicative of
ΔΨm dissipation (as verified for the control CCCP treatment).
We also investigated the effect of acetate on the levels of
mitochondrial proteins, namely the apoptosis-inducing factor
(AIF), the voltage dependent anion channel (VDAC1) and a
subunit of the outer mitochondrial membrane translocator
(TOM22). We found all doses of acetate, as well as etoposide,
increased the levels of AIFand VDAC1 in RKO and, to a higher
extent, in HCT-15 cells (Supplementary Figure S3). In addition,
acetate, but not etoposide, led to increased levels of TOM22.
Our results indicate that acetate causes mitochondrial
dysfunction, increasing ROS accumulation, perturbing ΔΨm
and increasing mitochondrial mass in a time- and dose-
dependent manner, suggesting that acetate impairs the
turnover of harmful mitochondria.
Acetate inhibits basal autophagy and impairs autophagy
induction. To determine if the increased mitochondrial mass
resulting from acetate exposure could be due to autophagy
inhibition, we monitored how it affects the levels of Beclin-1, a
well-known autophagic player that is part of the class III PI3K
complex. Acetate lowered Beclin-1 levels in both RKO and
HCT-15 cells, consistent with inhibition of autophagy and
possibly explaining the increased levels of mitochondrial
proteins in acetate-treated cells (Figure 2a). We next
determined whether acetate affects autophagy induction.
We monitored starvation-induced autophagy (in HBSS
medium) by assessing an autophagy hallmark: conversion
of LC3-I to LC3-II20 (in the presence and absence of
bafilomycin A1 (Baf. A1), a specific inhibitor of vacuolar type
H+-ATPase used to inhibit the fusion of autophagosomes with
lysosomes).21 HCT-15 and RKO cell lines had high basal
autophagy levels and did not induce autophagy in response
to starvation, evidenced by the increased accumulation of
LC3-II in the presence of Baf. A1 already in control cells,
which was not altered in response to starvation (Figures 2b–d).
Therefore, we could not determine whether acetate affects
autophagy induction in these cells. For that purpose, we
instead used the HCT116 cell line, which displays increased
autophagic flux in response to starvation (Figures 2b–d).
We found that a 48 h exposure of HCT116 cells to IC50,
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intermediate concentration and 2× IC50 of acetate
(Supplementary Figure S4) decreased conversion of LC3-I
to LC3-II in the presence of Baf. A1, which was even more
pronounced under starvation conditions (Figures 2e and f).
Increasing doses of acetate also progressively decreased the
levels of Beclin1 and Atg5 proteins, essential for autophago-
some completion,22,23 in both complete and starvation media
(Figure 2g). Taken together, our results indicate not only that
exposure to acetate does not induce autophagy under our
experimental conditions but also that it can inhibit both basal
autophagy and autophagy induction.
Active CatD mediates mitochondrial degradation and
protects CRC cells from acetate-induced mitochondrial
dysfunction. The cellular event or signal that determines
whether mitochondrial degradation in cancer cells under-
going apoptosis occurs through selective or nonselective
autophagy or by an autophagy-independent process, and
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Figure 1 Acetate induces oxidative stress and mitochondrial dysfunction in CRC cells. (a and b) HCT-15 and RKO cells were incubated with acetate (70, 100 or 140 mM for
HCT-15 cells; 110, 140 or 220 mM for RKO cells) for 12, 24 and 48 h. HCT-15- and RKO-negative control cells were incubated with fresh complete medium for the same times,
whereas positive control cells were incubated with 500 μM and 1 mM H2O2, respectively. (a) Accumulation of H2O2 in HCT-15 cells was detected with H2DCF-DA using a
fluorescence microplate reader. (b) Accumulation of superoxide anion (O2
−) in RKO cells was detected with DHE and quantified by flow cytometry. (c–e) Detection of mitochondrial
dysfunction in RKO cells using MitoTracker Green FM and MitoTracker Red CMXROs double staining. Cells were incubated with 110, 140 or 220 mM of acetate for up to 48 h and
then stained with 400 nM MitoTracker Green and 200 nM MitoTracker Red for 30 min at 37 ºC in the dark. (c) Representative histograms of mitochondrial dysfunction in cell
exposed to 110, 140 or 220 mM of acetate for 48 h. There was a significant increase in the green mean fluorescence intensity (MitoTracker Green), indicative of an increase in
mitochondrial mass, and a decrease in the mean red fluorescence intensity (MitoTracker Red CMXRos), indicative of changes in the ΔΨm. (d) Acetate treatment induces an
increase in the mean green fluorescence intensity normalized to the green mean fluorescence intensity at time 0 (T0), indicating an increase in mitochondrial mass. (e) Acetate
treatment induces an alteration in the ΔΨm normalized to mitochondrial mass, assessed by the ratio between the mean red fluorescence intensity (FL-4) and the mean green
fluorescence intensity (Fl-1) normalized to T0. For each time point, the values of at least three independent experiments are represented. Bonferroni’s test *P≤ 0.05; **P≤ 0.01
and ***P≤ 0.001 compared with negative control cells. In (c–e), cells were incubated with fresh complete medium or with 50 μM CCCP, which were used as a negative and
positive control, respectively
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which are the consequences to cell fate, is still unclear. In a
previous study in S. cerevisiae, we showed that the yeast
CatD (Pep4p) has an antiapoptotic role in acetic acid-induced
cell death that depends on its proteolytic activity, and is
required for mitochondrial degradation independently of
autophagy.14 We therefore hypothesized that CatD, similarly
to Pep4p, is required for efficient degradation of damaged
mitochondria. To test this hypothesis, we assessed how CatD
affects mitochondrial dysfunctions induced by acetate in
CRC cells.
We first analyzed whether Pepstatin A (PstA), a known
specific pharmacological inhibitor of CatD, or transfection with
specific RNA interference (siRNA) targeting CatD interfered
with acetate-induced accumulation of ROS in RKO cells. We
found that PstA increased total O2
− and H2O2 accumulation in
cells exposed to the three acetate concentrations for 24 h
(Figures 3a and b). Downregulation of CatD was even more
effective, as it significantly increased total and mitochondrial
O2
− accumulation in cells treated with 110mMacetate (detected
with DHE or MitoSOX, respectively) (Figures 3c and d).
In contrast, inhibition of CatD did not significantly affect
etoposide-induced ROS accumulation (Figures 3c and d).
We next tested the effect of depleting CatD onmitochondrial
mass. Transfection with CatD siRNA clearly increased the
levels of the mitochondrial protein AIF in both acetate- and
etoposide-treated RKO cells, although not in untreated
controls (Figure 4a). Using the double-staining protocol
described above, we also found that depletion of CatD in
acetate-treated RKO cells significantly increased mitochon-
drial mass and decreased ΔΨm. In contrast, it had no significant
effect in cells treated with etoposide (Figures 4b and c).
Altogether, these data indicate that CatD protects RKO cells
from mitochondrial dysfunction induced by acetate through its
involvement in the degradation of damaged mitochondria.
To further analyze whether the role of CatD in mitochondrial
degradation depends on its proteolytic activity, we assessed
how this parameter was affected by inhibition with PstA. PstA
significantly increased the mitochondrial mass of RKO cells
exposed to 110 and 140mM acetate for 48 h, but decreased
the ΔΨm (Figures 4d and e). In contrast, inhibition of CatD in
RKO cells exposed to etoposide did not affect mitochondrial
mass or the ΔΨm. Moreover, E-64d, an inhibitor of CatB and
CatL (also overexpressed in CRC cells),24 had no effect on the
mitochondrial mass or ΔΨm of either acetate- or etoposide-
treated cells (Figures 4d and e). We confirmed that E-64d
was active under our experimental conditions because it
decreased caspase-3 activity in cells exposed to etoposide
(not shown), confirming the previously described proapoptotic
function of CatB and CatL in this process.25 These results
indicate that CatD, but not CatL or CatB, is involved in
mitochondrial degradation in response to acetate. Accord-
ingly, we found that only the active form of CatD, but not CatL
and only trace amounts of CatB, is released to the cytosol after
acetate treatment (Figure 5).
The aforementioned results indicate that the role of CatD in
mitochondrial degradation depends on its proteolytic activity.
To further support this conclusion and determine whether this
mechanism is conserved, we assessed if the same is true for
the yeast CatD, and if human and yeast CatD are functionally
equivalent. For this purpose, we constructed strains deficient
in Pep4p expressing the empty vector control, and equivalent
levels of FLAG-tagged wild-type Pep4p, a double-point mutant
form deficient in proteolytic activity, and human CatD
(Figure 6a). We then compared their sensitivity to acetic acid
with that of wild-type W303 cells expressing the empty vector.
In accordance with our previous data,14 expression of wild-
type Pep4p, but not of the catalytically inactive mutant,
reverted the sensitivity of Pep4p-deficient cells to acetic
acid-induced apoptosis. Now, we further show that expression
of human CatD also compensates for the loss of Pep4p,
indicating that the two proteins have a similar role in this
process (Figure 6b). All strains were then transformed with a
plasmid expressing mitochondrial GFP, and mitochondrial
degradation in response to acetic acid was assessed by
estimating the percentage of cells with preserved green
fluorescence, as described previously.14 While expression of
wild-type Pep4p and CatD reverted the delay in mitochondrial
degradation of Pep4p-deficient cells exposed to acetic acid,
expression of double-point mutant Pep4p did not (Figure 6c).
Although the precise mechanism underlying the role of Pep4p
in cell survival and in mitochondrial degradation is still elusive,
we have now determined that both depend on its proteolytic
activity and are complemented by CatD. Taken together, our
results show that Pep4p/CatD is involved in acetic acid/
acetate-induced mitochondrial degradation independently of
autophagy but dependently of its catalytic activity in both yeast
and CRC cells.
Discussion
CRC is one of the most common solid tumors worldwide.2,26
A diet rich in dietary fiber is associated with a reduction in CRC
incidence,1,27 indicating CRC may be amenable to prevention
through a dietary regimen.15,16,27 Some of the significant
health benefits of dietary fiber can be attributed to its microbial
Figure 2 Acetate impairs autophagy in CRC cells. (a) Levels of Beclin-1 in cells exposed to acetate for 48 h (110 and 220 mM; 70 and 140 mM for RKO and HCT-15 cells,
respectively) (b) Immunoblot analysis of LC3-I/II in HCT116, RKO and HCT-15 cell lines. Cells were maintained in complete medium or incubated in HBSS medium (starvation) for
6 h in the presence and absence of 20 nM bafilomycin A1 (Baf. A1). The HCT116 cell line exhibited the strongest autophagic response to nutrient limitation (starvation) and thus
was chosen to address the effect of acetate on starvation-induced autophagy. (c) LC3-II/actin ratios of HCT116, RKO and HCT-15 cells were determined using Quantity One
software (Bio-Rad manufacturer). (d) The autophagic flux was determined by subtracting the normalized LC3-II levels in the presence of Baf. A1 from the corresponding levels
obtained in the absence of Baf. A1. (e) Levels of LC3-I/II and (g) of Beclin-1 and Atg5 in HCT116 cells exposed to acetate. Cells were left untreated (Blank) or treated with 100, 150
or 200 mM acetate for 42 h. Later, cells were maintained in complete medium or HBSS medium (starvation) with acetate for another 6 h in the presence or absence of 20 nM Baf.
A1. These data demonstrate that acetate decreases the autophagic flux in CRC cells in a dose-dependent manner, as shown by the decrease in LC3-II delivery to the lysosome,
and in Beclin-1 and Atg5 protein levels. (f) The LC3-II/actin ratios of HCT116 cells were determined using Quantity One software (Bio-Rad manufacturer). Actin was used as a
loading control. Values are mean±S.E.M. of three independent experiments. Representative immunoblots are shown in (a, b, e and g). One-way ANOVA followed by Bonferroni’s
test, ##P≤ 0.01 and ###P≤ 0.001 compared with control cells treated with HBSS (starvation medium)
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fermentation, namely by Propionibacteria in the colon into
SCFAs (acetate, propionate and butyrate).1,6,15,16,28 Indeed,
many studies suggest these SCFAs protect against carcino-
genesis, as they reduce human colon cancer cell growth and
differentiation and stimulate apoptosis in CRC cells.4,6,27,29
Acetate is one of the most important SCFAs, but has been less
investigated than propionate and butyrate. Nonetheless,
previous studies proposed that acetate inhibits proliferation
and induces apoptosis in colon cancer cells3–6 and that
acetate-induced apoptosis in CRC cells involves different
biochemical events, includingmitochondrial alterations.3–5We
have also previously shown that acetate induces apoptosis in
CRC-derived cells in a dose-dependent manner, character-
ized by DNA fragmentation, caspase-3 activation, phospha-
tidylserine exposure to the outer leaflet of the plasma
membrane and the appearance of a sub-G1 population5. In
addition, we showed that this process is associated with
lysosomal alkalinization, LMP and CatD release into the
cytosol.5
It is well established that partial LMP followed by a release of
lysosomal hydrolases into the cytosol can activate intrinsic
caspase-dependent apoptosis or a caspase-independent
alternative cell death pathway.7,8 Of these, CatD has emerged
as an important molecular target in cancer therapy, as it is
overexpressed and secreted by cells of various tumor types,
including CRC.30,31 CatD has a vital role in extracellular matrix
degradation and cancer cell survival, and actively participates
in the invasion of carcinoma cells during both local invasion
and metastasis formation.32,33 However, its role in apoptosis
depends on cellular types, specific contexts, stimulus and
catalytic activity.10,33 Our data indicate that CatD has a
protective role in acetate-induced apoptosis in CRC cells,5
as we had shown for its ortholog Pep4p in Saccharomyces
cerevisiae.13 As SCFAs, and in particular acetate, have
garnered increased interest as potential prevention/therapeu-
tic agents in CRC, we sought to further understand the
mechanism underlying the antiapoptotic role of this lysosomal
protease under this specific cellular and stimulus context.
Based on data from our group and others, as well as on the
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Figure 3 CatD protects CRC cells from oxidative stress. (a and b) Effect of PstA, a specific inhibitor of CatD catalytic activity, on ROS levels of RKO cells treated with acetate.
PstA (100 μM) was preincubated for 16 h and then coincubated with acetate for 24 h. (a) Accumulation of superoxide anion (O2
−) in RKO cells was detected with dihydroethidium
(DHE) and quantified by flow cytometry. (b) Accumulation of H2O2 in RKO cells was detected with H2DCF-DA using a fluorescence microplate reader. (c and d) Effect of CatD
silencing on mitochondrial superoxide and total superoxide production in RKO cells treated with acetate (110 mM) or etoposide (50 μM) for 48 h. As controls, RKO cells were not
transfected (blank), transfected with scrambled control siRNA or transfected with CatD siRNA. H2O2 (1 mM) was used as a positive control for ROS production. (c) Accumulation
of mitochondrial superoxide in RKO cells was detected with MitoSOX and quantified by flow cytometry. (c) Downregulation of CatD induces a significant increase in mitochondrial
superoxide production normalized to time 0 (T0) in RKO cells treated with 110 mM acetate and (d) a significant accumulation of total superoxide, normalized to T0 cells. Values
represent mean±S.E.M. of at least three independent experiments. *P≤ 0.05, **P≤ 0.01, ***P≤ 0.001 and ****P≤ 0.0001 compared with control cells. #P≤ 0.05 and
##P≤ 0.001 comparing acetate treatment with acetate/PstA or acetate treatment with acetate/CatD siRNA
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Figure 4 CatD is involved in autophagy-independent mitochondrial degradation in CRC cells. (a) Western blot of CatD isoforms (Pro-CatD, intermediate form and mature
CatD) and AIF with or without CatD silencing in the absence or presence of acetate (110 mM) or etoposide (50 μM). As controls, RKO cells were not transfected (blank),
transfected with scrambled control siRNA or transfected with CatD siRNA. Actin was used as a loading control. (b and c) Effect of CatD silencing on mitochondrial dysfunction in
RKO cells treated with acetate (110 mM) or etoposide (50 μM) for 48 h. (b) Downregulation of CatD induces a significant increase in mitochondrial mass normalized to time 0 (T0)
in RKO cells treated with 110 mM acetate and (c) a significant mitochondrial membrane depolarization normalized to mitochondrial mass, in relation to T0. For each bar, the mean
value for at least three independent experiments is represented. Bonferroni’s test, *P≤ 0.05; **P≤ 0.01 and ***P≤ 0.001 compared with negative control cells. #P≤ 0.05,
##P≤ 0.01 comparing acetate treatment with acetate/CatD siRNA. (d and e) Effect of the specific CatD inhibitor (PstA) and the CatB and CatL inhibitor (E-64d) on mitochondrial
dysfunction in RKO cells treated with acetate (110 and 140 mM) or etoposide (50 μM) for 48 h. E-64d (10 μM) and PstA (100 μM) were pre-icubated for 1 or 16 h, respectively, and
then coincubated with acetate or etoposide for 48 h. Cells were incubated with fresh complete medium or with 50 μM CCCP as a negative and positive control, respectively. Cells
were then double stained with 400 nM MitoTracker Green and 200 nM MitoTracker Red CMXRos for 30 min at 37 ºC in the dark and analyzed by flow cytometry. Inhibition of CatD
activity with PstA induces an increase in mitochondrial mass (d) and membrane depolarization normalized to mitochondrial mass in relation to T0 in RKO cells (e). For each bar,
the mean value for at least three independent experiments is represented. Bonferroni’s test *P≤ 0.05; **P≤ 0.01, ***P≤ 0.001 and ****P≤ 0.0001 compared with negative
control cells. #P≤ 0.05 comparing acetate treatment with acetate/PstA
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present study, we propose that the lysosome and mitochon-
dria communicate during acetate-induced apoptosis in CRC
cells through permeabilization of both organelles and selective
leakage of proteins. Indeed, we show that acetate triggers
release of CatD to the cytosol, but not of CatL, and only a small
amount of CatB, which does not seem to have major
consequences. Besides lysosomal alterations, acetate triggered
mitochondrial dysfunction in a dose- and time-dependent-
manner, characterized by increased mitochondrial ROS,
changes in ΔΨm and an increase in mitochondrial mass,
which were enhanced when CatD was inhibited. This
mitochondrial dysfunction is in agreement with that reported
during apoptosis induction by acetate and a mixture of acetate
and propionate produced by Propionibacterium freudenreichii
in other CRC cells (HT-29), including increased ROS and ΔΨm
dissipation, as well as swelling in isolated mitochondria.4
However, the role of CatD or the lysosome in that context was
not evaluated.
The increase in mitochondrial mass observed after expo-
sure of cells to acetate led us to investigate whether the
presumed decrease in mitochondrial turnover was associated
with modulation of autophagy by this SCFA. Previous
studies demonstrated that apoptosis triggered by low doses
(1–10mM) of propionate and butyrate can be delayed
because autophagy is also induced, which can potentially
impair the therapeutic efficacy of SCFAs in colon cancer.15–17
Indeed, autophagy has been implicated in cancer progres-
sion, used by cells for autophagic degradation of damaged
organelles, long-lived proteins and pathogens, and in this way
maintain homeostasis.20,29,34 Further assays are required to
ascertain whether low concentrations of acetate can cause a
similar adaptive response in CRC cells. However, we
previously showed that autophagy is not induced during
acetic acid-induced apoptosis in yeast.13 In the present study,
we demonstrate that acetate impairs the autophagic flux of
HCT116 cells and decreases Beclin-1 levels in all three cell
lines. Therefore, we show that concentrations of acetate
normally present in the human intestine have a previously
uncharacterized effect in CRC cells: inhibition of autophagy,
most likely through impairment of autophagosome and
lysosome fusion during acetate-induced apoptosis.
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Figure 6 Cell survival and mitochondrial degradation in S. cerevisiae cells during
acetic acid treatment. The W303 strain transformed with the empty vector (pESC) and
pep4Δ strains, transformed with the empty vector (pESC), pESC-PEP4 (expressing
WT-Pep4p), pESC-DPM (expressing DPM-Pep4p) or pESC-CTSD (expressing
human CatD), were incubated with 120 mM acetic acid for up to 180 min.
(a) Immunoblot analysis of whole-cell extracts of pep4Δ cells expressing FLAG-
tagged WT-Pep4p, FLAG-tagged DPM-Pep4p, FLAG-tagged CatD and the
corresponding empty vector after 20 h of growth. Pgk1p was used as a loading
control. (b) Cell survival at time 180 min was determined by standard dilution plate
counts and expressed as a percentage of colony-forming units (CFU) in relation to time
0. Data represents means±S.D. (n= 3). (c) Mitochondrial degradation was
assessed by measuring the percentage of cells without loss of mtGFP fluorescence
(100% corresponds to the number of GFP positive cells at time 0). Data represent
means± S.D. (n= 4). *Po0.05, **Po0.01 and ***Po0.001
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Figure 5 Acetate induces specific CatD release to the cytosol in CRC cells. Effect
of acetate on the expression and release of CatL, CatB and CatD to the cytosol in
RKO cells. Cells were treated with 110 mM acetate or 50 μM etoposide for 48 h, or
with fresh medium as a negative control. Total and cytosolic fractions (Cyto) are
shown. Actin was used as a loading control
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It is known that malfunctioning mitochondria are selectively
targeted for autophagic degradation.16 However, it is con-
ceivable that cells use alternative pathways to clear damaged
mitochondria when autophagy is inactive. We therefore
investigated if CatD is involved in mitochondrial degradation,
similar to Pep4p in yeast, possibly having a prosurvival role
through elimination of dysfunctional mitochondria. We show
that CatD protects RKO cells from acetate-induced oxidative
stress and mitochondrial depolarization, as its inhibition with
PstA or downregulation with siRNA cause a significant
increase in the levels of H2O2 and O2
− and a decrease in
ΔΨm. Hah et al.10 have previously suggested that CatD has a
protective role in H2O2-induced cell death in M059J glioblas-
toma cells through its involvement in autophagy, which
enhances cell survival under oxidative stress.10 Accordingly,
we had shown that Pep4p deletion increased the sensitivity of
yeast cells to acetic acid associated with increased ROS
accumulation,14 although autophagy was not induced.13
These data, together with our results, support the notion that
reduced CatD activity leads to increased ROS accumulation
and mitochondrial depolarization. We therefore proceeded to
determine whether CatD is involved in the degradation of
damagedmitochondria, aswe presumed to be the case during
acetate-induced apoptosis in CRC cells. We found that
downregulation of CatD in acetate-treated RKO cells
increased mitochondrial mass, as well as the cellular pool of
AIF. These findings corroborate our hypothesis that CatD is
involved in the degradation of damaged mitochondria during
acetate-induced apoptosis through an autophagy-
independent process. Although not sufficiently efficient to
maintain mitochondrial mass homeostasis, as an acetate-
induced increase in mitochondrial mass is still observed, this
alternative degradation process allows the cell to dispose of
dysfunctional mitochondria and delay cell death. It will be
interesting in the future to determine if CatD is also released
and is involved in mitochondrial degradation in response to
other SCFAs, either directly or through downstream sub-
strates. Inhibition of CatD with PstA mimicked the results
obtained with CatD siRNA, indicating the catalytic activity of
CatD is required for this function, as we previously found for
the antiapoptotic role of both yeast and human CatD.5,14 We
now also show that the role of yeast CatD in acetic acid-
induced mitochondrial degradation depends on its proteolytic
activity and can be complemented by human CatD, indicating
this mechanism is conserved through evolution.
As discussed above, partial LMP followed by a release of
lysosomal hydrolases into the cytosol can activate intrinsic
caspase-dependent apoptosis or a caspase-independent
alternative cell death pathway.7,8 Thus, disabling lysosome
function is under investigation as an adjuvant therapeutic
approach to sensitize cells to apoptosis-inducing agents.7
Destabilization of the lysosomal membrane has been pro-
posed as a promising strategy, as it would promote apoptosis
through initiation of the lysosomal pathway in cancer cells.8
However, our results show that the release of lysosomal
proteases, in particular of CatD,5 may enable a degradation
process alternative to autophagy with a similar protective role
in cell survival, thus counteracting activation of the lysosomal
death pathway. This would negatively impact the efficacy of
acetate, and probably of other therapeutic compounds that
trigger LMPand impair autophagy, andwould require inhibiting
CatD in combination treatments.
In summary, our findings based on the clues provided by the
yeast system unveiled a novel prosurvival function of CatD in
autophagy-independent mitochondrial degradation, which
can enhance cell survival in CRC cells undergoing acetate-
induced apoptosis. These results offer new perspectives in the
intricate regulation of life and death, and suggest using CatD
inhibitors as adjunct therapy with SCFAs for prevention/
therapy of CRC.
Materials and Methods
Cell lines and culture. We used three cell lines derived from human CRC,
namely RKOBRAFV600E, HCT-15KRASG13D and HCT116KRASG13D; PI3KCA. Cells were
maintained at 37 °C under a humidified atmosphere containing 5% CO2. HCT-15
cells were grown in RPMI (Biowest, Nuaillé, France) medium with L-glutamine and
HEPES. RKO cells were grown in DMEM (Biowest) with high glucose and
supplemented with 1 mM sodium pyruvate and 1.5 g/l sodium bicarbonate. HCT116
cells were grown in McCoy’s 5 A (Biowest) medium. All culture media were
supplemented with 10% fetal bovine serum and 100 U/ml penicillin/streptomycin.
For autophagy studies, we used HBSS (Gibco, Paisley, UK) medium supplemented
with 7.5% sodium bicarbonate.
Cell treatments with acetate. Cells were seeded and adhered onto
appropriate sterile plates for 24 h before treatments in all experiments.
We previously determined the IC50, IC intermediate (IC inter) and 2 × IC50 of
acetate after 48 h of treatment: 70, 100 and 140 mM for HCT-15; 110, 140 and
220 mM for RKO cell lines, respectively.5 The IC50, IC inter and 2 × IC50 values for
HCT116 (100, 150 and 200 mM, respectively) were calculated from the mean
values of sulforhodamine B reduction as described in Marques et al.5
(Supplementary Figure S3). For each bar, the mean value of at least three
independent experiments is represented. Bonferroni’s test: *P≤ 0.05, **P≤ 0.01
and ***P≤ 0.001 compared with negative control cells.
RNA interference-mediated inhibition of CatD. RKO cells were plated
in 6-well plates at a density of 3 × 104 cells per well. After 24 h, about 70%
confluence was confirmed before transfection with small interfering RNA (siRNA)
oligonucleotides. Cells were transfected with 100 nM on-target plus SMART pool
siRNA against CatD (A-003649-16; Thermo Fisher Scientific, Lafayette, CO, USA).
Transfection performance was monitored using a validated Silencer Select Negative
Control (scrambled siRNA control, no. 4390843; Life Technologies, Carlsbad, CA,
USA). Transfection was performed with 6 μl Lipofectamine 2000 (Invitrogen Corp.,
Paisley, UK). After 14 h, the transfection mixture was removed and cells were left
untreated (blank) or treated with acetate (110 mM) or etoposide (50 μM) and
incubated for a further 48 h in fresh medium. MitoSOx, DHE and double staining
with MitoTracker Green and Mitotracker Red CMXRos were performed as described
below. The experiments were carried out in three replicates, and CatD levels were
monitored by western blotting.
Determination of intracellular ROS
Dichlorofluorescein assay: Cells were seeded in a 12-well plate at a density
of 1.4× 105 and 1.8× 105 cells per well (RKO and HCT-15 cells, respectively).
When indicated, cells were preincubated with PstA (Sigma-Aldrich, St Louis, MO,
USA) for 16 h and then coincubated with PstA without and with different acetate
concentrations for 12, 24 and 48 h. After treatment, cells were washed two times
with 1x PBS and H2DCF-DA (Sigma-Aldrich) was added to the culture plates at a
final concentration of 100 μM. Plates were incubated at 37 °C for 30 min in the dark.
Then, cells were lysed with 500 μl of 90% DMSO/10% PBS (lysis solution) for
10 min at room temperature in the dark, with agitation. H2O2 (500 μM or 1 mM for
HCT-15 or RKO cell lines, respectively) was used as a positive control. H2DCF-DA
fluorescence intensity was detected with emission wavelength at 538 nm and
excitation wavelength at 485 nm using a fluorescence microplate reader
(Fluoroskan Ascent FL; Thermo Fisher Scientific Inc., Waltham, MA, USA). Values
are expressed as the mean fluorescence intensity normalized to the cell number in
each condition at the end of the experiment. Three independent experiments were
performed.
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DHE assay: Non-treated cells (negative control) or cells exposed to different
acetate concentrations for 12, 24 and 48 h were analyzed. When used, cells were
preincubated with PstA for 16 h and then coincubated with PstA without and with
different acetate concentrations for 24 h. Inhibition of CatD in RKO cells was
performed as described above. Approximately 1 × 106 floating and attached cells
were collected, washed with 1 × PBS, centrifuged at 1500 × g for 5 min and
incubated with 150 nM DHE (Molecular Probes, Eugene, OR, USA) (30 min, 37 °C,
in the dark) to detect superoxide anion (O2
−). Fluorescence emission of oxidized
DHE was analyzed by flow cytometry. H2O2 (500 μM or 1 mM for HCT-15 or RKO
cell lines, respectively) was used as a positive control. Values are expressed as the
mean of fluorescence intensity normalized to T0 (control for ROS level before the
treatment). Three independent experiments were carried out and data were
analyzed using the Flowing software (version 2.5.1, Turku Centre for Biotechnology,
Turku, Finland).
MitoSOX assay: MitoSOX Red (Molecular Probes) was used to detect
mitochondrial superoxide. Approximately 1 × 106 floating and attached cells were
collected, washed with 1x PBS, centrifuged at 1500 × g for 5 min and incubated with
2.5 μM MitoSOX Red for 30 min at room temperature. Fluorescence emission of
oxidized MitoSOX Red was analyzed by flow cytometry. H2O2 (1 mM) was used as a
positive control. Values are expressed as the percentage of cells with positive
staining normalized to T0 (control for ROS level before the treatment).
Analysis of mitochondrial alterations
Mitochondrial mass and ΔΨm analysis: MitoTracker Green FM (Molecular
Probes) was used to analyze the relative mitochondrial mass. MitoTracker Green is
a green fluorescent dye that localizes to the mitochondrial matrix regardless of the
ΔΨm and covalently binds to mitochondrial proteins by reacting with free thiol
groups of cysteine residues. MitoTracker Red CMXRos (Molecular Probes) was
used simultaneously, to monitor the changes in ΔΨm. MitoTracker Red CMXRos is
a red-fluorescent dye that stains mitochondria in live cells through accumulation in
mitochondria in a membrane potential-dependent manner. Untreated cells (negative
control), cells exposed to etoposide (50 μM), an inducer of LMP, or to different
acetate concentrations were analyzed at different time points. When used, cells
were preincubated with 10 μM (2S,3S)-trans-epoxysuccinyl-L-leucylamido-3-methyl-
butane ethyl ester (E-64d; Sigma-Aldrich) (a CatB and CatL inhibitor) or 100 μM
PstA for 1 and 16 h, respectively, and then co-incubated with different acetate
concentrations or etoposide for 48 h. Both floating cells and attached cells were
collected, washed with 1x PBS, centrifuged at 1500 × g for 5 min and incubated with
400 nM MitoTracker Green FM and 200 nM MitoTracker Red CMXRos (30 min, 37 °
C, in the dark). The uncoupling agent CCCP (50 μM, 30 min) was used as positive
control for mitochondrial membrane depolarization. Fluorescence emission was
analyzed by flow cytometry. The values of mitochondrial mass for each time point
were expressed as the ratio between the mean green fluorescence intensity and the
one correspondent to time zero (T0). The values of the ΔΨm for each time point
were expressed as the ratio between the mean red fluorescence intensity and the
mean green fluorescence intensity normalized to the correspondent one at T0.
Three independent experiments were carried out.
Fluorescence microscopy studies: Cells were seeded in 6-well
plates containing glass coverslips and exposed to acetate for 48 h. At the
end of the experiment, cells were washed with 1x PBS and incubated with 20 nM
DiOC6(3) (Molecular Probes) or with 400 nM MitoTracker Green and
200 nM MitoTracker Red CMXRos for 30 min, at 37 °C, in the dark. CCCP
(50 μM, 30 min) was also used as a positive control for ΔΨm loss. Coverslips
were mounted in 1x PBS and immediately observed under the fluorescence
microscope (Leica DM 5000B; Leica Microsystems, Wetzlar, Germany).
Three coverslips were prepared for each experimental condition and representa-
tive images are shown.
Flow cytometry analysis: Samples were analyzed in a flow cytometer
(Epics XL; Beckman Coulter, Miami, FL, USA) equipped with an argon-ion laser
emitting a 488-nm beam at 15 mW. Detection of red fluorescence was performed
using FL-4 (488/620 nm) and detection of green fluorescence was performed using
FL-1 (488/525 nm). A total of 30 000 cells were acquired per sample and data were
analyzed using the Flowing software (version 2.5.1, Turku Centre for Biotechnology).
Assessing autophagy in CRC cell lines: Cell lines untreated (Blank) or
treated with IC50, IC inter or 2 × IC50 acetate concentrations were incubated for 42 h
in complete medium. Later, cells were incubated in HBSS medium for 6 h in the
presence or absence of 20 nM Baf. A1 (Acros Organics, Geel, Belgium), in the
absence or presence of acetate.
Cell survival and mitochondrial degradation assays in yeast: Sacchar-
omyces cerevisiae strain W303-1A was used as the wild-type strain. The pep4Δ
mutant was constructed in W303-1A by homologous recombination using a PEP4::
kanMX4 disruption cassette amplified from the respective Euroscarf deletion strain
by PCR. Correct integration of the cassette was confirmed by PCR. To construct
CatDFLAG, the insert was amplified by PCR from the plasmid pJP1520-CTSD
(containing human CatD cDNA) and integrated by homologous recombination into
the pESC-His vector. Correct integration was verified by sequencing. The W303-1A
strain was transformed with the empty vector (pESC) and the pep4Δ strain was
transformed with the empty vector (pESC), pESC-PEP4, pESC-DPM and pESC-
CTSD plasmids for expression of WT-Pep4, double-point mutant (DPM-Pep4p) or
human CatD, respectively. The strains were transformed with the pGAL-CLbGFP
(see Okamoto et al.35) vector for mitochondrial degradation studies. Strain growth
conditions, acetic acid treatments and mitochondrial degradation assays were
performed as described previously.14
Preparation of total/cytosolic protein extracts and western blotting:
Cell lysis of mammalian cells, protein sample preparation (total and cytosolic) and
western blotting were carried out as described previously5 with 25 μg of total or
cytosolic extracted proteins applied per lane before SDS-PAGE. Total yeast extracts
were prepared by suspending ~ 2 × 106 cells in 0.5 ml of water and adding 50 μl of a
mixture of 3.5% β-mercaptoethanol in 2 M NaOH. After a 15min incubation on ice,
proteins were precipitated with 50 μl of 3 M trichloracetic acid for 15 min on ice. After a
rapid centrifugation, the pellet was resuspended in Laemmli buffer for SDS-PAGE.
The primary antibodies used were anti-Beclin-1 (1 : 3000; Cell Signaling
Technology, Leiden, Netherlands), anti-LC3-II (1 : 5000; Sigma-Aldrich), anti-Atg5
(1 : 3000; Sigma-Aldrich), anti-CatD (1 : 100; Calbiochem, San Diego, CA, USA), anti-
CatB (1 : 300; Abcam, Cambridge, UK), anti-CatL (1 : 1000; Abcam), anti-AIF
(internal) rabbit polyclonal antibody (1 : 500; Chemicon International, Billerica, MA,
USA ), anti-VDAC1 (1 : 2000; MitoSciences, Eugene, OR, USA), anti-Tom22 (FL-145)
(1 : 1000; Santa Cruz Biotechnology, Santa Cruz, CA, USA), anti-actin (Santa Cruz
Biotechnology, Santa Cruz), anti-FLAG (1 : 5000; Sigma-Aldrich) and anti-yeast
phosphoglycerate kinase (PGK1) antibody (1 : 5000; Molecular Probes). Secondary
antibodies used were peroxidase-conjugated AffiniPure goat anti-rabbit IgG (Jackson
ImmunoResearch, West Grove, PA, USA) and horseradish peroxidase-labeled goat
anti-mouse immunoglobulin IgG (Jackson ImmunoResearch). Subsequent chemilu-
minescence detection was performed using the ECL detection system (Amersham,
Biosciences, Buckinghamshire, UK) and a molecular imager by Chemi-Doc XRS
system (Bio-Rad, Laboratories Inc., Hercules, CA, USA). When performed,
densitometry analysis of protein bands was performed using the Quantity One
software (version 4.6.9, Bio-Rad manufacturer, Hercules, CA, USA) and levels of actin
used as a normalization control for protein loading.
Statistical analysis: Data are expressed as mean± S.D. of three independent
experiments. Statistical significance analysis was determined by one-way ANOVA
followed by Dunnett or Bonferroni’s test for multiple comparisons with the control
using Prism software (GraphPad, La Jolla, CA, USA). The differences were
considered significant for P-values lower than 0.05.
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